| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
44,961 |
33,860 |
$1.12M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,182 |
4,241 |
$140K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
9,593 |
8,246 |
$102K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,914 |
3,227 |
$99K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
5,401 |
4,566 |
$92K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,967 |
2,302 |
$79K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,330 |
2,635 |
$65K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,234 |
1,072 |
$40K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,081 |
889 |
$39K |
| 36415 |
Collection of venous blood by venipuncture |
18,760 |
14,047 |
$24K |
| 3008F |
|
11,941 |
9,484 |
$21K |
| 90671 |
|
1,631 |
1,349 |
$19K |
| 90461 |
|
1,337 |
1,103 |
$16K |
| 83655 |
|
3,608 |
2,626 |
$10K |
| 90620 |
|
1,130 |
963 |
$9K |
| 90734 |
|
1,647 |
1,382 |
$8K |
| 90656 |
|
4,530 |
3,923 |
$6K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
229 |
189 |
$6K |
| 90651 |
|
1,772 |
1,473 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
680 |
428 |
$4K |
| 86580 |
|
1,066 |
941 |
$4K |
| 36406 |
|
817 |
625 |
$4K |
| 36410 |
|
2,204 |
1,629 |
$3K |
| 90710 |
|
483 |
399 |
$3K |
| 90670 |
|
642 |
602 |
$2K |
| 92551 |
|
310 |
305 |
$2K |
| 99383 |
|
64 |
44 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
224 |
102 |
$1K |
| 99381 |
|
40 |
37 |
$1K |
| 90723 |
|
632 |
546 |
$1K |
| 90633 |
|
1,502 |
1,152 |
$902.20 |
| 90715 |
|
600 |
510 |
$873.22 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
16 |
14 |
$629.72 |
| 90680 |
|
539 |
459 |
$598.03 |
| 90696 |
|
327 |
271 |
$586.45 |
| 99382 |
|
88 |
15 |
$574.70 |
| 90698 |
|
302 |
273 |
$556.50 |
| 99177 |
|
484 |
482 |
$513.70 |
| 99000 |
|
16,348 |
11,927 |
$500.22 |
| 97803 |
|
13,464 |
11,469 |
$441.29 |
| 99173 |
|
1,246 |
796 |
$380.00 |
| 90716 |
|
132 |
108 |
$349.66 |
| 90655 |
|
126 |
110 |
$331.88 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
45 |
43 |
$299.96 |
| 96127 |
|
157 |
104 |
$172.96 |
| 90700 |
|
87 |
73 |
$170.22 |
| 90647 |
|
564 |
451 |
$117.40 |
| 90648 |
|
695 |
531 |
$116.14 |
| H0033 |
Oral medication administration, direct observation |
62 |
61 |
$110.00 |
| 90707 |
|
56 |
53 |
$92.49 |
| 90744 |
|
146 |
123 |
$85.08 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
25 |
15 |
$14.50 |
| 99070 |
|
298 |
214 |
$6.00 |
| 90681 |
|
62 |
62 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
34 |
28 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
72 |
45 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
25 |
15 |
$0.00 |